UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 151 - 200 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer - Abstract
Wednesday, 09 September 2009
Department of Preventive Medicine, Keck School of Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA.
read more

Incidental detection of granulomatous prostatitis by F-18 FDG PET/CT in a patient with bladder cancer: a rare complication of BCG instillation therapy - Abstract
Tuesday, 08 September 2009
Visart Medical Imaging Center, Ankara, Turkey.
read more

Urothelial carcinoma following augmentation cystoplasty: an aggressive variant with distinct clinicopathological characteristics and molecular genetic alterations - Abstract
Tuesday, 08 September 2009
Department of Pathology, Chang Gung Memorial Hospital-Kaohsiung Medical Centre, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
read more

The value of urinary cytology in the diagnostic of high grade urothelial tumors - Abstract
Tuesday, 08 September 2009
Klinik für Urologie, Universitätsklinikum, Hufelandstrasse 55, 45122, Essen, Germany.
read more

Genetic susceptibility to distinct bladder cancer subphenotypes - Abstract
Monday, 07 September 2009
Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
read more

Predictive value of urinary interleukin-8 cutoff point for recurrences after transurethral resection plus induction bacillus calmette-guérin treatment in non-muscle-invasive bladder tumors - Abstract
Monday, 07 September 2009
Third Urology Clinic, Ministry of Health, Yildirim Beyazit Training Hospital, Ankara, Turkey.
read more

Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract - Abstract
Monday, 07 September 2009
Academic Department of Urology of Lille University Hospital, Lille, and Academic Department of Urology of la Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine Pierre et Marie Curie, University Paris VI, Paris, France.
read more

Predictors of false positives in 5-aminolevulinic acid-induced photodynamic diagnosis of bladder carcinoma: Identification of patient groups that may benefit most from highly specific optical diagnostics - Abstract
Friday, 04 September 2009
Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
read more

Fibrin clot inhibitor medication and efficacy of Bacillus Calmette-Guerin for bladder urothelial cancer - Abstract
Friday, 04 September 2009
Section of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
read more

Cost-effectiveness analysis of immediate radical cystectomy versus intravesical Bacillus Calmette-Guerin therapy for high-risk, high-grade (T1G3) bladder cancer - Abstract
Friday, 04 September 2009
Division of Urology, Department of Surgical Oncology, University Health Network, Toronto, Ontario, Canada.
read more

Endo Pharmaceuticals introduces VALSTAR™ (valrubicin) to fill unmet need in aggressive form of bladder cancer
Thursday, 03 September 2009
CHADDS FORD, PA, USA (Press Release) - September 3, 2009
read more

Beyond the Abstract - Micronutrient intake and risk of urothelial carcinoma in a prospective Danish cohort, by Nina Roswall, M.Sc., PhD-student
Thursday, 03 September 2009
BERKELEY, CA (UroToday.com) - Approximately 90% of all bladder cancers are urothelial carcinomas, originating in the epithelial bladder cells.
Login to read more...

Optical biopsy of human bladder neoplasia with in vivo confocal laser endomicroscopy - Abstract
Thursday, 03 September 2009
Department of Urology, Stanford University School of Medicine, Stanford, California.
read more

Longer wait times increase overall mortality in patients with bladder cancer - Abstract
Thursday, 03 September 2009
Department of Health Policy, Management and Evaluation, University Health Network, Toronto, Canada.
read more

Combined thermo-chemotherapy for recurrent bladder cancer after Bacillus Calmette-Guerin - Abstract
Thursday, 03 September 2009
Urology Departments, Bnai-Zion Medical Center, Haifa, Israel.
read more

Renal transplant recipients and patients with end stage renal disease present with more advanced bladder cancer - Abstract
Thursday, 03 September 2009
Department of Urology, University of Virginia, Charlottesville, Virginia.
read more

Beyond the Abstract - The current role of telomerase in the diagnosis of bladder cancer, by Sara Bravaccini, MD
Wednesday, 02 September 2009
BERKELEY, CA (UroToday.com) - One of the main interests of our research group is the investigation of molecular markers for non-invasive early diagnosis of human tumors, among which bladder cancer occupies an important position.
Login to read more...

Incidences of kidney, pelvis, ureter, and bladder cancer in a nationwide, population-based cancer registry, Denmark, 1944-2003 - Abstract
Wednesday, 02 September 2009
Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark.
read more

Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples - Abstract
Wednesday, 02 September 2009
OncoMethylome Sciences SA, Liège, Belgium.
read more

Inhibition of bladder tumour growth by histone deacetylase inhibitor - Abstract
Wednesday, 02 September 2009
Department of Urology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
read more

Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers - Abstract
Wednesday, 02 September 2009
Department of Urology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, United States.
read more

BJUI Mini Reviews - Secondary neoplasms of the urinary system and male genital organs
Tuesday, 01 September 2009
This review provides a discussion of those secondary tumours involving the urinary system and male genital organs that can pose differential diagnostic difficulties with primary lesions, and highlights morphological and ancillary features that could be helpful in reaching a proper assignment of primary origin.
Login to read more...

Hexyl aminolevulinate fluorescence cystoscopy in bladder cancer - Abstract
Tuesday, 01 September 2009
Department for Urology, University of Tuebingen, Germany.
read more

miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy - Abstract
Tuesday, 01 September 2009
The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
read more

Conservative treatment of invasive bladder cancer - Abstract
Tuesday, 01 September 2009
Department of Radiation Oncology, McGill University Health Centre, Montreal, QC.
read more

Hexvix® has been granted priority review by the FDA
Monday, 31 August 2009
OSLO, NORWAY (Press Release) - August 31, 2009
read more

BJUI Mini Reviews - The role of lymphangiogenesis in lymphatic tumour spread of urological cancers
Monday, 31 August 2009
This article summarizes preliminary evidence on the role of lymphangiogenesis during the formation of lymphatic metastasis in the most common urological cancers.
Login to read more...

A 10-year retrospective review of a nonrandomized cohort of 458 patients undergoing radical radiotherapy or cystectomy in Yorkshire, UK - Abstract
Monday, 31 August 2009
Department of Urology, Mid Yorkshire NHS Trust, Pinderfields Hospital, Aberford Road, Wakefield.
read more

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells - Abstract
Monday, 31 August 2009
Institute for Stem Cell Biology and Regenerative Medicine, Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA 94304-5542, USA.
read more

Early assessment for bladder cancer could improve early detection rates for women
Friday, 28 August 2009
BEDFORD, UK (Press Release) PRLog - August 28, 2009
read more

URS 2009 - Heme oxygenase-1 expression correlates with chemo-resistance against intravesical administration of anthracycline antitumor drugs in non-muscle invasive bladder cancer - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - Heme oxygenase (HO) is a microsomal late-limiting enzyme in heme degradation. HO-1 is normally found at a faint expression level, but is upregulated for an adaptive response to various stress stimuli, such as oxidative stress, hypoxia, and hyperthermia.
Login to read more...

URS 2009 - Metabonomics in bladder cancer detection - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - Cystoscopy is considered as the current gold standard for diagnosis of bladder carcinoma.
Login to read more...

URS 2009 - Prediction of response to intravesical BCG by genome-wide cDNA microarray analysis: In primary T1 bladder cancer - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - While intravesical administration of bacillus Calmette–Guérin (BCG) following resection of non-muscle invasive bladder cancer (BC) is the current ‘gold standard’, many patients will fail to response.
Login to read more...

URS 2009 - Invasive TCC in the Elderly: Radical cystectomy? - Abstract
Friday, 28 August 2009
PORT DOUGLAS, AUSTRALIA (UroToday.com) - To reduce morbidity in the elderly patient, conservative multimodal therapy concepts for invasive bladder cancer are emerging as an alternative to radical cystectomy.
Login to read more...

Bladder tumor in women with microscopic hematuria: an Iranian experience and a review of the literature - Abstract
Friday, 28 August 2009
Dr. Taheri Medical Research Group, Baqiyatallah Research Center for Gastroenterology and Liver diseases, Baqiyatallah Hospital, Mullasadra Ave, Tehran 1435915371, Iran.
read more

Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: Role of thymidine kinase 2 - Abstract
Thursday, 27 August 2009
Department of Oncology, University of Alberta and Cross Cancer Institute, Edmonton, Alberta, Canada T6G 1Z2.
read more

Diagnosis of bladder cancer with microelectromechanical systems-based cystoscopic optical coherence tomography - Abstract
Thursday, 27 August 2009
Department of Biomedical Engineering, SUNY at Stony Brook, Stony Brook, New York, USA.
read more

Beyond the Abstract - Office cystoscopy and transrectal ultrasound-guided prostate biopsies pose minimal risk: Prospective evaluation of 921 procedures, by Surena F. Matin, MD
Wednesday, 26 August 2009
BERKELEY, CA (UroToday.com) - The Institute of Medicine has drawn professional and public attention to the safety of patients in our health care system through two prominent publications.
Login to read more...

Increased cancer risk of augmentation cystoplasty: Possible role for hyperosmolal microenvironment on DNA damage recognition - Abstract
Wednesday, 26 August 2009
Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, MLC 7022, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, United States.
read more

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma - Abstract
Wednesday, 26 August 2009
Divisions of Urologic Surgery, Nuclear Medicine, Anatomic and Molecular Pathology, Diagnostic Radiology, and Biostatistics; Departments of Surgery and Pathology and Immunology; Mallinckrodt Institute of Radiology; and Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO.
read more

Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12 - Abstract
Tuesday, 25 August 2009
Laboratory of Tumor Immunology Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA.
read more

Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer - Abstract
Tuesday, 25 August 2009
Department of Urology, Institute of Health Biosciences, University of Tokushima Graduate School, Tokushima, Japan.
read more

Maratona Urológica 2009 - Scientific Program
Tuesday, 25 August 2009
Login to read more...

Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development - Abstract
Monday, 24 August 2009
Department of Molecular Medicine, Arhus University Hospital, Skejby, Denmark.
read more

Prognostic significance of neuron-associated protein expression in non-muscle-invasive urothelial bladder cancer - Abstract
Monday, 24 August 2009
Department of Pathology and Laboratory Medicine at Roswell Park Cancer Institute, Elm and Carlton Street, Buffalo, NY 14263, USA.
read more

Secondary neoplasms of the urinary system and male genital organs - Abstract
Friday, 21 August 2009
Department of Pathology, Reina Sofia University Hospital and Faculty of Medicine, Cordoba, Spain.
read more

Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06 - Abstract
Friday, 21 August 2009
Departments of Radiation Oncology and Urology, and the Division of Hematology and Oncology, Massachusetts General Hospital, Boston MA.
read more

Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer - Abstract
Friday, 21 August 2009
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, P. R. China.
read more

Acute and late toxicity in radical radiotherapy for bladder cancer - Abstract
Thursday, 20 August 2009
To evaluate the incidence, severity and kinetics of acute and late toxicity from bladder and bowels in patients with bladder cancer treated with radical radiotherapy.
read more

Clinical outcome in a contemporary series of restaged patients with clinical T1 bladder cancer - Abstract
Wednesday, 19 August 2009
Division of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts